SAFAT, Kuwait

Khaled Orabi

This inventor holds 1 USPTO granted patent. Top assignee: Kuwait University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Khaled Orabi. Retrieved from https://idiyas.com/inventor/khaled-orabi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Khaled Orabi and His Anti-Inflammatory Patent.

Introduction

Khaled Orabi is an inventor based in Safat, Kuwait. His patent work focuses on an anti-inflammatory composition and its potential use in preventing or reducing inflammation, including inflammation associated with asthma.

Latest Patents

Orabi is associated with 1 patent, titled “Anti-inflammatory composition and method of treatment.” The invention describes a composition containing onion bulb extract and one or more glucocorticosteroids, particularly a low-dose glucocorticosteroid. It may be administered to help prevent or reduce inflammation, including inflammation resulting from asthma, and may be used for people at risk of developing asthma to help prevent its progression. The described approach may reduce pEGFR levels or inhibit other inflammatory pathways.

Career Highlights

Orabi is associated with Kuwait University. His patent reflects research into combining onion bulb extract with glucocorticosteroids as a potential approach to inflammation and asthma.

Collaborations

His listed coworkers include Ahmed El-hashim and Maitham Abbas Khajah.

Conclusion

Khaled Orabi’s patent work at Kuwait University centers on a proposed anti-inflammatory composition with potential applications in asthma prevention and treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…